4598Delta-Fly Pharma4598 info
$3.83info1.48%24h
Global rank28451
Market cap$27.41M
Change 7d-10.47%
YTD Performance-44.86%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Delta-Fly Pharma (4598) Stock Overview

    Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 that is in phase III clinical trial in the United States and phase I trial in Japan for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323, which is in phase III clinical trial to treat lung cancer; DFP-17729 that is in phase I/II clinical trials for the treatment of solid cancer; DFP-11207, which has completed phase I clinical trial to treat pancreatic cancer; DFP-14927 that is in phase I for the treatment of hematologic cancer; and DFP-10825, which is in preclinical trial to treat gastric/ovarian cancer. Delta-Fly Pharma, Inc. was incorporated in 2010 and is headquartered in Tokushima, Japan.

    4598 Stock Information

    Symbol
    4598
    Address
    37-5 NishikinoTokushima, 771-0116Japan
    Founded
    -
    Trading hours
    -
    Website
    https://www.delta-flypharma.co.jp
    Country
    πŸ‡―πŸ‡΅ Japan
    Phone Number

    Delta-Fly Pharma (4598) Price Chart

    -
    Value:-

    Delta-Fly Pharma Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.83
    N/A
    Market Cap
    $27.41M
    N/A
    Shares Outstanding
    7.15M
    N/A
    Employees
    11.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org